Inovio Pharmaceuticals (INO)
(Delayed Data from NSDQ)
$11.13 USD
+0.07 (0.63%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $11.14 +0.01 (0.09%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Brokerage Reports
Inovio Pharmaceuticals, Inc. [INO]
Reports for Purchase
Showing records 301 - 320 ( 364 total )
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
On the Road to Curing Cancer: Recent Developments and Future Outlook
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Ebola Trial Initiated; 2015 1Q Financial Results; Reiterate Buy
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: CHEN Y
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Hepatitis B Trial Initiation; Strong T Cell Responses in Head and Neck Cancer; Reiterate Buy
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: CHEN Y
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Inovio Leads $45 Million Ebola Program; Reiterate Buy
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: CHEN Y
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Full-Year 2014 Financial Results; Reiterate Buy
Provider: H.C. WAINWRIGHT & CO., INC.
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
King of Synthetic Vaccines; Initiate with Buy and $17 Price Target
Provider: H.C. WAINWRIGHT & CO., INC.
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Interim Analysis of the Phase I Reported Unprecedented Immune Responses.
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Interim Analysis of the Phase I Reported Unprecedented Immune Responses.
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Initiates a Phase I Trial of Universal Flu Vaccine in Elderly
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Inovio Initiates a Phase I Trial of Universal Flu Vaccine in Elderly
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
We are placing Inovio Pharmaceuticals under review due to the departure of the covering analyst
Provider: RODMAN & RENSHAW, CO.
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
SYNCON BASED AVIAN FLU VACCINE - MULTIPLE TRIALS GENERATING TITERS
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
SYNCON BASED AVIAN FLU VACCINE - MULTIPLE TRIALS GENERATING TITERS
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R